News

A New MRI Device Offers Improved Breast Cancer Diagnosis
With VIDA, Sheba offers earlier and more accurate detection of breast cancer
Read More

Sheba and Mayo Clinic Partner to Transform Patient Care Through an Innovative Data-Sharing Network
Sheba Medical Center has joined the Mayo Clinic Platform Connect, a global data-sharing network that aims to revolutionize healthcare. The groundbreaking platform provides a safe, cloud-based framework to access de-identified clinical data across three continents while ensuring that each organization retains complete control over its medical records. “We are thrilled to be part of this […]
Read More

Enhancing Patient Safety and Care with AI Solutions
With improving patient care a top priority, Sheba recognized technological innovation as an essential enabler of progress and transformation, with a particular emphasis on artificial intelligence. According to Prof. Eyal Zimlichman, Sheba’s Chief Transformation and Innovation Officer as well as Founder and Director of the ARC Innovation Center, “In terms of patient safety, we’ve made […]
Read More

Meet the IBD Passport: A New Hope for Ulcerative Colitis and Crohn’s Disease Patients
Ulcerative colitis (UC) and Crohn’s disease, the two most common forms of inflammatory bowel disease (IBD), can cause frustrating symptoms like diarrhea, abdominal pain, bloating, constipation, weight loss, and fatigue. Trips away from home can be logistically and physically challenging for people with IBD. Travelers with UC and Crohn’s can experience symptomatic flare-ups during their […]
Read More

Antibody Levels Remain High Two Months After Receiving the Second Dose of the COVID-19 Vaccine
According to the latest data, the Pfizer-BioNTech COVID-19 vaccine remains effective for at least two months after receiving the second jab. Click here to learn more.
Read More

Sheba and CAPS Medical Partner to Assess a New Bladder Cancer Treatment
Non-muscle invasive bladder cancer (NMIBC) develops in the tissue that lines the bladder’s inner surface. NMIBC is characterized by a high recurrence rate of up to 80%, which means that, in most cases, the conventional therapeutic approach does not eliminate the malignancy. Traditionally, NMIBC is treated via transurethral resection of bladder tumor (TURBT), a surgical […]
Read More

Sheba Has Been Designated an Official Micra Pacemaker Training Center
A pacemaker, also called a cardiac pacing device, is a small apparatus that’s placed (implanted) in the chest to help control the heartbeat by sending electrical pulses. It keeps the heart beating regularly and prevents it from beating too slowly. However, pacemaker implantation involves a complicated surgical procedure. In 2006, Medtronic made history by being […]
Read More

New Hope for Peritoneal Cancer Patients
Peritoneal cancer is a rare malignancy that develops in the peritoneum, a membrane that lines the walls of the abdominal cavity and rests on the abdominal and pelvic organs. Whether originating from a primary tumor within the peritoneum or a metastatic tumor elsewhere in the body, peritoneal cancer is a terminal disease with a poor […]
Read More